1. Home
  2. QUIK vs ANTX Comparison

QUIK vs ANTX Comparison

Compare QUIK & ANTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo QuickLogic Corporation

QUIK

QuickLogic Corporation

HOLD

Current Price

$16.51

Market Cap

211.8M

Sector

Technology

ML Signal

HOLD

Logo AN2 Therapeutics Inc.

ANTX

AN2 Therapeutics Inc.

HOLD

Current Price

$4.71

Market Cap

170.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
QUIK
ANTX
Founded
1988
2017
Country
United States
United States
Employees
51
N/A
Industry
Semiconductors
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
211.8M
170.6M
IPO Year
1997
2022

Fundamental Metrics

Financial Performance
Metric
QUIK
ANTX
Price
$16.51
$4.71
Analyst Decision
Buy
Buy
Analyst Count
1
1
Target Price
$11.00
$2.00
AVG Volume (30 Days)
376.6K
319.0K
Earning Date
05-12-2026
05-13-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
32.56
EPS
N/A
N/A
Revenue
$20,112,000.00
N/A
Revenue This Year
$75.17
N/A
Revenue Next Year
$16.04
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$4.80
$1.00
52 Week High
$16.89
$6.91

Technical Indicators

Market Signals
Indicator
QUIK
ANTX
Relative Strength Index (RSI) 73.88 68.40
Support Level $5.67 $1.06
Resistance Level N/A $6.91
Average True Range (ATR) 1.24 0.36
MACD 0.35 0.10
Stochastic Oscillator 90.67 80.79

Price Performance

Historical Comparison
QUIK
ANTX

About QUIK QuickLogic Corporation

QuickLogic Corp is a fabless semiconductor company developing programmable logic semiconductor technologies, including embedded Field Programmable Gate Array (eFPGA) intellectual property (IP) and specialized FPGA devices. Its product offerings include the eFPGA IP licensing business and associated professional services, as well as a range of FPGA silicon products, including EOS, ArcticLink III, PolarPro 3, PolarPro II, PolarPro, and Eclipse II products, among others. The company's customers come from various markets, including aerospace and defense, industrial and infrastructure systems, data processing and computing platforms, and certain embedded and edge computing applications. Geographically, it generates maximum revenue from North America and the rest from Asia Pacific and Europe.

About ANTX AN2 Therapeutics Inc.

AN2 Therapeutics Inc is a biopharmaceutical company focused on discovering and developing novel small molecule therapeutics derived from its boron chemistry platform. The company has a pipeline of boron-based compounds in development for Chagas disease, non-tuberculous mycobacterial (NTM) and melioidosis, along with early-stage programs focused on targets in infectious diseases and oncology. Product candidate AN2-502998 Epetraborole.

Share on Social Networks: